These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6491393)

  • 1. Complement sensitivity of erythroid and myeloid precursors in paroxysmal in nocturnal hemoglobinuria.
    Ishida Y; Matsumoto N; Shinohara K; Yamada K; Inoue M; Kaneko T; Murphy MJ
    Int J Cell Cloning; 1984 Sep; 2(5):316-26. PubMed ID: 6491393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity to complement of erythroid and myeloid progenitors in paroxysmal nocturnal hemoglobinuria.
    Dessypris EN; Clark DA; McKee LC; Krantz SB
    N Engl J Med; 1983 Sep; 309(12):690-3. PubMed ID: 6888440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria.
    Moore JG; Humphries RK; Frank MM; Young N
    Exp Hematol; 1986 Mar; 14(3):222-9. PubMed ID: 3512279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
    Okuda K; Kanamaru A; Ueda E; Kitani T; Okada N; Okada H; Kakishita E; Nagai K
    Exp Hematol; 1990 Nov; 18(10):1132-6. PubMed ID: 1698649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased resistance of PIG-A- bone marrow progenitors to tumor necrosis factor a and interferon gamma: possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones.
    Barcellini W; Fermo E; Guia Imperiali F; Zaninoni A; Bianchi P; Boschetti C; Zanella A
    Haematologica; 2004 Jun; 89(6):651-6. PubMed ID: 15194531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement sensitivity of paroxysmal nocturnal hemoglobinuria bone marrow cells.
    Tumen J; Kline LB; Fay JW; Scullin DC; Reisner EG; Rosse WF; Huang AT
    Blood; 1980 Jun; 55(6):1040-6. PubMed ID: 6246993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of GPI-anchor proteins during the differentiation from hematopoietic progenitors in patients with paroxysmal nocturnal hemoglobinuria].
    Kanamaru A; Nishimura T
    Rinsho Ketsueki; 1994 Apr; 35(4):358-63. PubMed ID: 8028180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic progenitor cells in the blood and bone marrow in various hematologic disorders.
    Issaragrisil S; U-pratya Y; Yimyam M; Pakdeesuwan K; Khuhapinant A; Muangsup W; Pattanapanyasat K
    Stem Cells; 1998; 16 Suppl 1():123-8. PubMed ID: 11012154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of mixed erythroid-granulocytic colonies in culture derived from bone marrow of patients with paroxysmal nocturnal hemoglobinuria without addition of exogenous stimulator.
    Issaragrisil S; Piankijagum A; Chinprasertsuk S; Kruatrachue M
    Exp Hematol; 1986 Oct; 14(9):861-6. PubMed ID: 3758236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM; Schönermark S; Roelcke D
    J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.